Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Data-Driven Stratification Reveals 3 Distinct Clinicopathologic Phenotypes in Renal Thrombotic Microangiopathy.
Journal: Mayo Clinic proceedings. Digital health
Published: May 25, 2026
Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: March 09, 2026
The Clinicopathologic Characteristics of Recurrent Lupus Nephritis Post-Transplant Using Surveillance and Indication Biopsies.
Journal: Kidney international reports
Published: February 18, 2025
Evaluation for genetic disease in kidney transplant candidates: A practice resource.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: August 17, 2024
Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).
Journal: Journal of translational medicine
Published: April 30, 2024
Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).
Journal: Journal of translational medicine
Published: February 22, 2023
Corrigendum to Heybeli C, Bentall A, Wen J, et al. A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis. Kidney Int. 2021;99:707-715.
Journal: Kidney international
Published: November 22, 2021
Death With Function and Graft Failure After Kidney Transplantation: Risk Factors at Baseline Suggest New Approaches to Management.
Journal: Transplantation direct
Published: October 12, 2021
Diffuse C4d staining of peritubular capillaries in renal allograft following bamlanivimab therapy.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: April 18, 2021
Response to "Fibroblast Growth Factor 23 Is a Valuable Predictor of Autosomal Dominant Polycystic Kidney Disease Progression".
Journal: Kidney international reports
Published: March 07, 2021
Last Updated: 09/26/2026